(Q36533402)

14 August 2017

1 reference

title

Immunobiology of Toll-like receptors: emerging trends (English)

1 reference

14 August 2017

0 references

Saumya Pandey

1

1 reference

PubMed ID

16834572

14 August 2017

Devendra K Agrawal

series ordinal

2

1 reference

14 August 2017

1 August 2006

1 reference

Immunology & Cell Biology

14 August 2017

1 reference

14 August 2017

84

1 reference

14 August 2017

4

1 reference

14 August 2017

333-341

1 reference

Toll-like receptors: critical proteins linking innate and acquired immunity

14 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Lipopolysaccharide and double-stranded RNA up-regulate toll-like receptor 2 independently of myeloid differentiation factor 88.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

The extracellular toll-like receptor 2 domain directly binds peptidoglycan derived from Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

mRNA is an endogenous ligand for Toll-like receptor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

The extra domain A of fibronectin activates Toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Intracellular Recognition of Lipopolysaccharide by Toll-like Receptor 4 in Intestinal Epithelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Mouse toll-like receptor 4.MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Recognition of single-stranded RNA viruses by Toll-like receptor 7

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Topical delivery of imiquimod to a mouse model as a novel adjuvant for human immunodeficiency virus (HIV) DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

The polarity of the dorsoventral axis in the Drosophila embryo is defined by an extracellular signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Drosophila Toll and IL-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

The molecular structure of the Toll-like receptor 3 ligand-binding domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

The evolution and genetics of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Mammalian Toll-like receptors: to immunity and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

TLR3 and TLR7 are targeted to the same intracellular compartments by distinct regulatory elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Porphyromonas gingivalis lipopolysaccharide antagonizes Escherichia coli lipopolysaccharide at toll-like receptor 4 in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Different domains of Pseudomonas aeruginosa exoenzyme S activate distinct TLRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Human airway epithelial cells sense Pseudomonas aeruginosa infection via recognition of flagellin by Toll-like receptor 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

A molecule that is associated with Toll-like receptor 4 and regulates its cell surface expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta (TRIF)-dependent pathway in TLR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

TAK1 is a ubiquitin-dependent kinase of MKK and IKK

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Essential function for the kinase TAK1 in innate and adaptive immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Triggering the interferon antiviral response through an IKK-related pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Negative regulation of Toll-like-receptor signaling by IRF-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

"Host tissue damage" signal ATP promotes non-directional migration and negatively regulates toll-like receptor signaling in human monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

IRAK-M is a negative regulator of Toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Negative regulation of toll-like receptor-mediated signaling by Tollip

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Re-examination of the role of suppressor of cytokine signaling 1 (SOCS1) in the regulation of toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

C5a negatively regulates toll-like receptor 4-induced immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Epidermal growth factor receptor acts as a negative regulator for bacterium nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via an Src-dependent p38 mitogen-activated protein kinase signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Identification and characterization of a novel bacterial virulence factor that shares homology with mammalian Toll/interleukin-1 receptor family proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Toll-like receptor 4 polymorphism and severity of atopy in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Up-regulation of Toll-like receptors 2, 3 and 4 in allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Regulation of lung injury and repair by Toll-like receptors and hyaluronan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Bacterial lipopolysaccharide signaling through Toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

High mobility group box 1 protein interacts with multiple Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Toll-like receptor 4 or 2 agonists decrease allergic inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Toll-like receptor 4 signaling regulates cytosolic phospholipase A2 activation and lipid generation in lipopolysaccharide-stimulated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Proinflammatory phenotype of vascular smooth muscle cells: role of efficient Toll-like receptor 4 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Toll-like receptors in the pathogenesis of human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Toll-like receptor 2 (TLR2) mediates intracellular signalling in human keratinocytes in response to Malassezia furfur.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Toll-like receptor 3 and STAT-1 contribute to double-stranded RNA+ interferon-gamma-induced apoptosis in primary pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Toll-like receptors 2 and 4 are differentially involved in Fas dependent apoptosis in Peyer's patch and the liver at an early stage after bile duct ligation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Lipopolysaccharide signals an endothelial apoptosis pathway through TNF receptor-associated factor 6-mediated activation of c-Jun NH2-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

The apoptotic signaling pathway activated by Toll-like receptor-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Th1-like cytokine induction by heat-killed Brucella abortus is dependent on triggering of TLR9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Control of adaptive immune responses by Toll-like receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Toll-like receptor control of the adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Interleukin-12 and the regulation of innate resistance and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Maturation of dendritic cell 2 phenotype by a helminth glycan uses a Toll-like receptor 4-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

TLR ligands can activate dendritic cells to provide a MyD88-dependent negative signal for Th2 cell development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Regulation of phagosome maturation by signals from toll-like receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Enhanced Dendritic Cell Antigen Capture via Toll-Like Receptor-Induced Actin Remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

HIV impairs TNF-alpha release in response to Toll-like receptor 4 stimulation in human macrophages in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Disabling surveillance: bacterial type III secretion system effectors that suppress innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Pharmacological inhibition of endotoxin responses is achieved by targeting the TLR4 coreceptor, MD-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Toll-like receptor stimulation induces airway hyper-responsiveness to bradykinin, an effect mediated by JNK and NF-kappa B signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

TLR2 agonist ameliorates established allergic airway inflammation by promoting Th1 response and not via regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

The TLR7 agonist imiquimod enhances the anti-melanoma effects of a recombinant Listeria monocytogenes vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

Toll-like Receptor 4 Polymorphisms and Atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01444.X

10.1111/J.1440-1711.2006.01444.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16834572